Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of NeurAxon
Exited company

NeurAxon Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2007
Fund
Diversified Portfolio
Learn More
About the company

NeurAxon is a leader in discovering and developing next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating chronic pain and central nervous system neuronal sensitization.